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Myo-inositol (MI) is one of the stereoisomers of hexahydrox-
ycyclohexane, which plays an important role in intracellular
signal pathway. Derivatization is an indispensable step in
both external and internal standard method during the
chromatography-mass spectrometer (GC–MS) detection, as MI
can’t be ionized directly. It is valuable to optimize the derivative
process and the detection volume for clinical detection. This
article contains optimization data related to research publication
“Quantiﬁcation of plasma myo-inositol using gas chromato-
graphy–mass spectrometry” [1]. Here we introduce the data on
the optimized derivatization volume, temperature, duration and
the detection volume.
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Value of the data
 The data for the optimized derivatization volume, temperature, duration and the detection volume
is presented;
 Periphery blood is enough for the detection of plasma MI;
 The optimized derivatization condition for MI analysis could be used not only for biological spe-
cimens, but also for food and others.1. Data
This data consist of the optimal derivatization condition of MI, including amount of derivatization
reagent, derivative temperature and derivative time (Figs. 1 and 2). Furthermore, the detection
volume of the plasma was minimized (Table 1).Fig. 1. Total ion chromatogram (TIC) proﬁles of GC–MS results.
Fig. 2. Optimal derivatization conditions for plasma MI detection. The derivatization reagent amount (A) derivative tem-
perature (B) and derivative time (C) were optimized.
Table 1
Optimize the plasma volume for MI detection.
Injection volume
(μL)
Peak area MI concentrion
(μg/L)
Ratio (MI concentrion/
Injection volume)
10 1142317 5 0.50
30 2205462 87 2.90
50 2556501 136 2.72
70 3211173 181 2.59
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2.1. Gas chromatography instrument and reagents
The gas chromatography instrument and reagents were used as our previous study [1].
2.2. Optimal derivatization condition of MI
Derivatization is an important and vital step in pretreatment process in GC–MS analysis [2,3].
Derivatization conditions were optimized by using a 5 mg/l MI working solution, which was placed
into 30 μl human plasma. The various amount of derivatization reagent (1 ml, 3 ml, 5 ml, 8 ml, 10 ml,
13 ml and 15 ml), derivative temperature (65 °C, 70 °C, 75 °C, 80 °C and 85 °C) and derivative time
(15 min, 30 min, 45 min, 60 min, 75 min, 90 min and 105 min) were investigated. The peak area of
various derivatization conditions was analyzed and results were shown in Fig. 1. It was found that the
derivatization yield increased as the increase of reaction volume less than 5 ml. 5 ml reagent was
observed to be sufﬁcient for derivatization. So did the situation when the derivative temperature
above 70 °C and the derivative duration longer than 60 min (Fig. 2). Therefore, it was determined that
the optimized derivatization conditions were using a 5 ml mixture of TMCS/HMDS/N, N - DMF at
70 °C for 60 min and shaking at 10 min intervals.
2.3. Optimal the volumes of plasma for detection
To minimize the detection volume of the plasma, various volumes of plasma samples (10 μl, 30 μl,
50 μl and 70 μl) were pretreated and evaluated by GC–MS method. The result showed that the
plasma volume was proportional to the concentration of the plasma MI from 70 μl to 30 μl of the
detection volume. Therefore, 30 μl was the minimal volume for detection (Table 1).Acknowledgments
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